18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR-IOR-15006942
尚未开始
/
/
/
2015-08-20
/
/
Degenerative osteoarthritis of the knee
比較膝關節内注射間充質幹細胞及透明質酸用於治療膝關節炎的效用
比較膝關節内注射間充質幹細胞及透明質酸用於治療膝關節炎的效用
比較膝關節内注射間充質幹細胞及透明質酸用於治療膝關節炎的效用
随机平行对照
其它
Randomized
/
The Chinese University of Hong Kong
/
30
/
1990-01-01
1990-01-01
/
Patients must comply with all the following criteria in order to be included in the study 1. Male and female subjects aged between 18 and < 65; 2. All patients must provide their written consent; 3. All patients must be affected by primary osteoarthritis of the knee (according to ACR - American College of Rheumatology - classification); In case a patient shows a bilateral OA, it will be included and treated for both knees; 4. All patients must have pain symptoms since at least 2 months; 5. All patients must experience, during the inclusion visit (T0), a pain level higher than or equal to 5.0 cm on a VAS scale of 10 cm; 6.All patients should have at least 8 years of school education; 7.Radiological evidence of osteoarthritis with Kellgren and Lawrence grade 2 and 3.;
登录查看The presence of one or more of the following criteria will exclude the patient from the study: 1. Patients with previous cases of alcoholism or drug abuse; 2. Pregnancy and breast-feeding; 3. Presence of serious pathologies; 4. Hypersensitivity towards hyaluronic acid; 5. Intra-articular infiltrations of hyaluronic acid or steroids that are in the process of being administered or that have been interrupted since less than 3 months; 6. Steroid-based systemic therapy in progress or interrupted since less than 1 month and/or anti-clotting drugs; 7. History of fractures and/or severe traumas of the knee bone; 8. Significant hematologic diseases; 9. Non-consenting patients who have not provided the written Informed Consent; 10. Mechanical instability, ligamentous laxity/deficiency and gross deformity; 11. Isolated meniscal tear without evident of osteoarthritis.;
登录查看Prof. Kevin HO Ki Wai
/
约印创投2025-01-16
求实药社2025-01-16
Genhouse2025-01-16
IPHASE2025-01-16
动脉网2025-01-16
动脉网-最新2025-01-16
药明康德2025-01-16
药明康德2025-01-16
再鼎医药2025-01-16
Rimonci2025-01-15